You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

COVID-19 Financing Framework - April 17, 2020

Getinge has seen an increased global demand for advanced ventilators, extra corporeal life support (ECLS) equipment and advanced monitoring for Intensive Care Units since the outbreak of the COVID-19 pandemic. To meet the global demand, Getinge will temporarily increase its production of advanced ICU-ventilators by 160% in 2020, to 26,000 ventilators in total. In order to facilitate this expansion of production capacity, Getinge may need external financing. In order to provide disclosure and transparency to investors on the direct link between this financing and the use of proceeds for the expansion of production capacity, Getinge has developed a COVID-19 Financing Framework together with SEB.

April 17

Getinge has seen an increased global demand for advanced ventilators, extra corporeal life support (ECLS) equipment and advanced monitoring for Intensive Care Units since the outbreak of the COVID-19 pandemic. To meet the global demand, Getinge will temporarily increase its production of advanced ICU-ventilators by 160% in 2020, to 26,000 ventilators in total. In order to facilitate this expansion of production capacity, Getinge may need external financing. In order to provide disclosure and transparency to investors on the direct link between this financing and the use of proceeds for the expansion of production capacity, Getinge has developed a COVID-19 Financing Framework together with SEB.

Event details

Date: April 17

Download the financing framework